Nadroparin-induced skin necrosis: clinical manifestation of HIT-2 even in the absence of thrombocytopaenia.
Department of Internal Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Diego Luis Carrillo
DL
Pérez
Department of Dermatology, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
Adriana Guadalupe
AG
Peña-Romero
Department of Dermatology, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
José Manuel
JM
Díaz-González
Department of Dermatology, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
Judith
J
Domínguez-Cherit
D000328:Adult; D006801:Humans; D008297:Male; D017762:Nadroparin / Q000009:adverse effects*; D009336:Necrosis; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology; D013921:Thrombocytopenia / Q000139:chemically induced*
D017762:Nadroparin